Zhiwan Wang
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Nanoparticle-Based Drug Delivery 8
- Silk-based biomaterials and applications 1
-
- Nanoplatforms for cancer theranostics 8
- Co-authors
- Zhiwen Zhang (10 shared papers)Tao Tan (8 shared papers)Hong Wang (7 shared papers)Jie Li (6 shared papers)Yaping Li (7 shared papers)Siling Wang (4 shared papers)Haiyan Hu (2 shared papers)Xiaoxuan Xu (3 shared papers)
- Journals
- Advanced Functional Materials (3 papers)Journal of Evidence-Based Medicine (1 paper)Acta Pharmaceutica Sinica B (1 paper)Advanced Science (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- China
In The Last Decade
Zhiwan Wang
19 papers receiving 763 citations
Peers
Comparison fields: 5 of 75
- Biomaterials 311
- Biomedical Engineering 537
- Immunology 128
- Cancer Research 85
- Oncology 124
Countries citing papers authored by Zhiwan Wang
This map shows the geographic impact of Zhiwan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiwan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiwan Wang more than expected).
Fields of papers citing papers by Zhiwan Wang
This network shows the impact of papers produced by Zhiwan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiwan Wang. The network helps show where Zhiwan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhiwan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 149 | |
| 2 | 2019 | 120 | |
| 3 | 2021 | 86 | |
| 4 | 2018 | 82 | |
| 5 | 2018 | 77 | |
| 6 | 2017 | 59 | |
| 7 | 2019 | 52 | |
| 8 | 2018 | 40 | |
| 9 | 2019 | 33 | |
| 10 | 2020 | 29 | |
| 11 | 2013 | 13 | |
| 12 | 2016 | 9 | |
| 13 | 2018 | 9 | |
| 14 | [An expert analysis of diagnostic criteria for traditional Chinese medicine syndromes of chronic obstructive pulmonary disease at acute exacerbation stage]. | 2011 | 3 |
| 15 | Strategies and practice research for the treatment of chronic obstructive pulmonary disease by traditional Chinese medicine | 2012 | 2 |
| 16 | 2014 | 2 | |
| 17 | Study on literature-based distribution regularity of TCM syndromes in COPD patients at acute exacerbation stage | 2008 | 1 |
| 18 | 2023 | 1 | |
| 19 | 2017 | 1 |
About Zhiwan Wang
Zhiwan Wang is a scholar working on Biomaterials, Biomedical Engineering, Molecular Biology, Complementary and alternative medicine and Cancer Research, having authored 19 papers that have together received 768 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (8 papers), Traditional Chinese Medicine Studies (4 papers), RNA Interference and Gene Delivery (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer Cells and Metastasis (2 papers), Extracellular vesicles in disease (2 papers) and Silk-based biomaterials and applications (1 paper). The work is most often cited by research in Biomaterials (311 citations), Biomedical Engineering (537 citations), Immunology (128 citations), Cancer Research (85 citations) and Oncology (124 citations). Zhiwan Wang has collaborated with scholars based in China. Frequent co-authors include Zhiwen Zhang, Tao Tan, Hong Wang, Jie Li, Yaping Li, Siling Wang, Haiyan Hu, Xiaoxuan Xu, Xiang Gong and Haiqiang Cao. Their work appears in journals such as Advanced Functional Materials, Journal of Evidence-Based Medicine, Acta Pharmaceutica Sinica B, Advanced Science and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.